De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)

Table 2 Examples of potential pilot de-implementation interventions

Formulary restriction
Prior authorization - Oncology consultation - Pharmacy review	Used in infectious disease
Criteria for use - EMR order template - Selected prescribers	Currently used for restricted drugs
Medication safety (VAMedSAFE)	Evaluate, educate, and prevent adverse events
Decision-making
Decision aid using a brief in-office pro/con (e.g., Option Grid™)	Commercialized shared decision-making for prostate cancer
Provider training in communication and values elicitation	Evidence-based practice though difficult to implement/sustain
Informed consent for ADT	VA iMed consent

ISSN: 1748-5908